These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30395685)

  • 21. A single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models.
    Yu L; Baxter PA; Zhao X; Liu Z; Wadhwa L; Zhang Y; Su JM; Tan X; Yang J; Adesina A; Perlaky L; Hurwitz M; Idamakanti N; Police SR; Hallenbeck PL; Blaney SM; Chintagumpala M; Hurwitz RL; Li XN
    Neuro Oncol; 2011 Jan; 13(1):14-27. PubMed ID: 21075780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity and protective efficacy of an inactivated cell culture-derived Seneca Valley virus vaccine in pigs.
    Yang F; Zhu Z; Cao W; Liu H; Zhang K; Tian H; Liu X; Zheng H
    Vaccine; 2018 Feb; 36(6):841-846. PubMed ID: 29310900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I clinical study of Seneca Valley Virus (SVV-001), a replication-competent picornavirus, in advanced solid tumors with neuroendocrine features.
    Rudin CM; Poirier JT; Senzer NN; Stephenson J; Loesch D; Burroughs KD; Reddy PS; Hann CL; Hallenbeck PL
    Clin Cancer Res; 2011 Feb; 17(4):888-95. PubMed ID: 21304001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and evaluation of a real-time RT-PCR and a field-deployable RT-insulated isothermal PCR for the detection of Seneca Valley virus.
    Zhang J; Nfon C; Tsai CF; Lee CH; Fredericks L; Chen Q; Sinha A; Bade S; Harmon K; Piñeyro P; Gauger P; Tsai YL; Wang HT; Lee PA
    BMC Vet Res; 2019 May; 15(1):168. PubMed ID: 31126297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cryo-Electron Microscopy Structure of Seneca Valley Virus Procapsid.
    Strauss M; Jayawardena N; Sun E; Easingwood RA; Burga LN; Bostina M
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RIG-I is responsible for activation of type I interferon pathway in Seneca Valley virus-infected porcine cells to suppress viral replication.
    Li P; Zhang X; Cao W; Yang F; Du X; Shi Z; Zhang M; Liu X; Zhu Z; Zheng H
    Virol J; 2018 Oct; 15(1):162. PubMed ID: 30352599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rescue of NanoLuc luciferase-expressing Senecavirus A with oncolytic activity.
    Liu F; Wang Q; Huang Y; Wang N; Shan H
    Virus Res; 2021 Jan; 292():198232. PubMed ID: 33207264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation and diagnostic application of monoclonal antibodies against Seneca Valley virus.
    Yang M; van Bruggen R; Xu W
    J Vet Diagn Invest; 2012 Jan; 24(1):42-50. PubMed ID: 22362934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics.
    Corbett V; Hallenbeck P; Rychahou P; Chauhan A
    Front Mol Biosci; 2022; 9():930207. PubMed ID: 36090051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seneca Valley Virus 2C and 3C
    Liu T; Li X; Wu M; Qin L; Chen H; Qian P
    Front Microbiol; 2019; 10():1202. PubMed ID: 31191506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncolytic Virotherapy by HSV.
    Watanabe D; Goshima F
    Adv Exp Med Biol; 2018; 1045():63-84. PubMed ID: 29896663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental Seneca Valley virus infection in market-weight gilts.
    Buckley A; Kulshreshtha V; van Geelen A; Montiel N; Guo B; Yoon KJ; Lager K
    Vet Microbiol; 2019 Apr; 231():7-10. PubMed ID: 30955826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolutionary analysis of 3 isolates of Seneca Valley virus from a single pig farm.
    Dong J; Rao D; Geng X; Chen M; He S; Jiao F; Huang L; Chen B; Zhao P; Cong F
    Can J Vet Res; 2022 Apr; 86(2):102-107. PubMed ID: 35388228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNAs are associated with Seneca Valley virus infection.
    Zhu M; Cai Y; Zhao W; He C; Yang Y; Gao Q; Su S
    Vet Microbiol; 2020 Jul; 246():108728. PubMed ID: 32605750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intercellular transmission of Seneca Valley virus mediated by exosomes.
    Xu G; Xu S; Shi X; Shen C; Hao J; Yan M; Zhang D; Zhu Z; Zhang K; Zheng H; Liu X
    Vet Res; 2020 Jul; 51(1):91. PubMed ID: 32678013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Distribution of Different Clades of Seneca Valley Viruses in Guangdong Province, China.
    Chen P; Yang F; Cao W; Liu H; Zhang K; Liu X; Xu Z; Zhu Z; Zheng H
    Virol Sin; 2018 Oct; 33(5):394-401. PubMed ID: 30328012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncolytic virotherapy.
    Sze DY; Reid TR; Rose SC
    J Vasc Interv Radiol; 2013 Aug; 24(8):1115-22. PubMed ID: 23885911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and full-genome sequencing of Seneca Valley virus in piglets from China, 2016.
    Qian S; Fan W; Qian P; Chen H; Li X
    Virol J; 2016 Oct; 13(1):173. PubMed ID: 27756396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Comparative Safety Profile Assessment of Oncolytic Virus Therapy Based on Clinical Trials.
    Matsuda T; Karube H; Aruga A
    Ther Innov Regul Sci; 2018 Jul; 52(4):430-437. PubMed ID: 29714547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncolytic Virus: Regulatory Aspects from Quality Control to Clinical Studies.
    Yamaguchi T; Uchida E
    Curr Cancer Drug Targets; 2018; 18(2):202-208. PubMed ID: 28228083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.